These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12612852)

  • 21. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project.
    Fratiglioni L; Winblad B; von Strauss E
    Physiol Behav; 2007 Sep; 92(1-2):98-104. PubMed ID: 17588621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
    Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
    Wilkinson D; Andersen HF
    Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory drugs and Alzheimer's disease.
    Martyn C
    BMJ; 2003 Aug; 327(7411):353-4. PubMed ID: 12919966
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy--is there a place for its use in neurology?
    Vuković V; Lovrencić-Huzjan A; Solter VV; Dordević V; Demarin V
    Coll Antropol; 2003 Jun; 27(1):413-24. PubMed ID: 12974172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk and protective factors for sporadic Alzheimer's disease.
    Stozická Z; Zilka N; Novák M
    Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure and dementia.
    Birkenhäger WH; Staessen JA
    Panminerva Med; 2004 Dec; 46(4):227-37. PubMed ID: 15876979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.
    Bornebroek M; de Lau LM; Haag MD; Koudstaal PJ; Hofman A; Stricker BH; Breteler MM
    Neuroepidemiology; 2007; 28(4):193-6. PubMed ID: 17851257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thinking preventively about dementia: a review.
    Cooper B
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):895-906. PubMed ID: 12325048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology of Alzheimer's disease: methodological approaches and new perspectives].
    Berr C; Vercambre MN; Akbaraly TN
    Psychol Neuropsychiatr Vieil; 2009 Dec; 7 Spec No 1():7-14. PubMed ID: 20061228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alzheimer's disease and treatment of vascular risk factors].
    de Leeuw FE; van Norden AG; van der Flier WM; Olde Rikkert MG; Scheltens P
    Ned Tijdschr Geneeskd; 2005 Dec; 149(51):2844-9. PubMed ID: 16398165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aromatase enzyme and Alzheimer's disease.
    Hiltunen M; Iivonen S; Soininen H
    Minerva Endocrinol; 2006 Mar; 31(1):61-73. PubMed ID: 16498364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.
    Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Lazzeroni L; Rasgon NL
    Acta Neurol Scand; 2009 Mar; 119(3):172-9. PubMed ID: 18705678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.
    Reddy PH; McWeeney S
    Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.